The role of hyperthermia in amphetamine's interactions with NMDA receptors, nitric oxide, and age to produce neurotoxicity.
D000375:Aging / Q000502:physiology*; D000661:Amphetamine / Q000633:toxicity*; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000502:physiology* / Q000503:physiopathology; D016291:Dizocilpine Maleate / Q000494:pharmacology; D005334:Fever / Q000503:physiopathology*; D018698:Glutamic Acid / Q000378:metabolism; D006220:Haloperidol / Q000494:pharmacology; D008694:Methamphetamine / Q000633:toxicity*; D019331:NG-Nitroarginine Methyl Ester; D009498:Neurotoxins / Q000633:toxicity*; D009569:Nitric Oxide / Q000037:antagonists & inhibitors / Q000502:physiology*; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000502:physiology*; D013237:Stereoisomerism
D009498:Neurotoxins; D016194:Receptors, N-Methyl-D-Aspartate; D009569:Nitric Oxide; D018698:Glutamic Acid; D008694:Methamphetamine; D016291:Dizocilpine Maleate; D001120:Arginine; D000661:Amphetamine; D006220:Haloperidol; D019331:NG-Nitroarginine Methyl Ester